A major study published in The Lancet in 2024 revealed that neurological conditions affected over 3 billion people globally in 2021, making them the leading cause of illness and disability. The economic burden of brain disorders is projected to reach 16 trillion dollars by 2030. Companies like Neuralink and Neuroelectrics, founded by Ana Maiques and Giulio Ruffini, are advancing neurotechnology. Maiques discusses the potential of neurotechnology to treat medical conditions and enhance understanding of the brain, while emphasizing the non-invasive approach of Neuroelectrics' products. Teljes cikk (Euronews.com)